The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
iNova Pharmaceuticals, in consultation with the TGA, has initiated a recall of one batch of Kynd Stress Relief tablets following reports of unexpected allergic reactions.
The affected batch number is 106585 (expiry 08/2023).
Kynd Stress Relief is a listed medicine traditionally used to decrease symptoms of mild anxiety.
What should I do?
If you or someone you care for is taking Kynd Stress Relief tablets, check the batch number displayed on the bottle.
If the bottle is from batch 106585 (expiry 08/2023), immediately stop using the product and return it to the place of purchase for a refund.
If you have any questions or concerns, contact the iNova Pharmaceuticals team on 1800 630 056 or your health professional.
Pharmacies, other retailers and wholesalers who have purchased this product are advised to inspect stock immediately and quarantine all units from the affected batch. All unsold units of the affected batch will be removed from the market.
What symptoms should I be aware of?
Some users of Kynd Stress Relief tablets have reported experiencing allergic reactions. Symptoms of allergic reactions can include:
- rash
- tingling or burning sensation on the skin
- general skin redness and itching
- swelling of the throat, tongue, eyelids and/or face.
If you experience these or any other unexpected symptoms after taking Kynd Stress Relief tablets, please seek immediate medical advice.
The investigation into the cause of the reported allergic reactions is ongoing.
Reporting problems
Consumers and health professionals are encouraged to report problems with medicines or vaccines. Your report will contribute to the TGA's monitoring of these products.
The TGA cannot give advice about an individual's medical condition. You are strongly encouraged to talk with a health professional if you are concerned about a possible adverse event associated with a medicine or vaccine.